Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 2293 entries
Sorted by: Best Match Show Resources per page
Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences.

Patient preference and adherence

Brinkman WB, Epstein JN.
PMID: 21311701
Patient Prefer Adherence. 2011 Jan 17;5:45-56. doi: 10.2147/PPA.S10647.

BACKGROUND: Attention-deficit/hyperactivity disorder (ADHD) is a common condition that often results in child and family functional impairments. Although there are evidence-based treatment modalities available, implementation of and persistence with treatment plans vary with patients. Family preferences also vary and...

Cite
Brinkman WB, Epstein JN. Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence. 2011;5:45-56doi: 10.2147/PPA.S10647.
Brinkman, W. B., & Epstein, J. N. (2011). Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient preference and adherence, 545-56. https://doi.org/10.2147/PPA.S10647
Brinkman, William B, and Epstein, Jeffery N. "Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences." Patient preference and adherence vol. 5 (2011): 45-56. doi: https://doi.org/10.2147/PPA.S10647
Brinkman WB, Epstein JN. Treatment planning for children with attention-deficit/hyperactivity disorder: treatment utilization and family preferences. Patient Prefer Adherence. 2011 Jan 17;5:45-56. doi: 10.2147/PPA.S10647. PMID: 21311701; PMCID: PMC3034298.
Copy Download .nbib Format: NLM
Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment.

Patient preference and adherence

Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L.
PMID: 24833896
Patient Prefer Adherence. 2014 May 02;8:621-9. doi: 10.2147/PPA.S60771. eCollection 2014.

BACKGROUND: Subcutaneous or intravenous immunoglobulin replacement is the mainstay of treatment for most patients with primary immunodeficiency disease (PID). The purpose of this study was to gain an understanding of how existing PID therapies affect patient lives and to...

Cite
Espanol T, Prevot J, Drabwell J, et al. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014;8:621-9doi: 10.2147/PPA.S60771.
Espanol, T., Prevot, J., Drabwell, J., Sondhi, S., & Olding, L. (2014). Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient preference and adherence, 8621-9. https://doi.org/10.2147/PPA.S60771
Espanol, Teresa, et al. "Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment." Patient preference and adherence vol. 8 (2014): 621-9. doi: https://doi.org/10.2147/PPA.S60771
Espanol T, Prevot J, Drabwell J, Sondhi S, Olding L. Improving current immunoglobulin therapy for patients with primary immunodeficiency: quality of life and views on treatment. Patient Prefer Adherence. 2014 May 02;8:621-9. doi: 10.2147/PPA.S60771. eCollection 2014. PMID: 24833896; PMCID: PMC4014377.
Copy Download .nbib Format: NLM
Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer.

Patient preference and adherence

Hua CH, Guo HM, Guan XL, Kong FJ, Hou RJ, Zhang XY, Li SR.
PMID: 24204125
Patient Prefer Adherence. 2013 Oct 17;7:1061-6. doi: 10.2147/PPA.S52498. eCollection 2013.

PURPOSE: The aim of our study was to assess, for the first time, the validity, reliability, and acceptability of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life questionnaire (QLQ) cervical cancer module (CX24) in...

Cite
Hua CH, Guo HM, Guan XL, et al. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient Prefer Adherence. 2013;7:1061-6doi: 10.2147/PPA.S52498.
Hua, C. H., Guo, H. M., Guan, X. L., Kong, F. J., Hou, R. J., Zhang, X. Y., & Li, S. R. (2013). Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient preference and adherence, 71061-6. https://doi.org/10.2147/PPA.S52498
Hua, Cai-Hong, et al. "Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer." Patient preference and adherence vol. 7 (2013): 1061-6. doi: https://doi.org/10.2147/PPA.S52498
Hua CH, Guo HM, Guan XL, Kong FJ, Hou RJ, Zhang XY, Li SR. Validation of the European Organization for Research and Treatment of Cancer cervical cancer module for Chinese patients with cervical cancer. Patient Prefer Adherence. 2013 Oct 17;7:1061-6. doi: 10.2147/PPA.S52498. eCollection 2013. PMID: 24204125; PMCID: PMC3804534.
Copy Download .nbib Format: NLM
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review.

Patient preference and adherence

Mravčík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B.
PMID: 24204126
Patient Prefer Adherence. 2013 Oct 17;7:1067-75. doi: 10.2147/PPA.S49113.

INTRODUCTION AND METHODS: Hepatitis C virus (HCV) infections are highly prevalent amongst people who inject drugs (PWID). Despite well documented evidence of its effectiveness, suggested cost-effectiveness, and potential to reduce HCV prevalence rates, the uptake of antiviral HCV treatment...

Cite
Mravčík V, Strada L, Stolfa J, et al. Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence. 2013;7:1067-75doi: 10.2147/PPA.S49113.
Mravčík, V., Strada, L., Stolfa, J., Bencko, V., Groshkova, T., Reimer, J., & Schulte, B. (2013). Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient preference and adherence, 71067-75. https://doi.org/10.2147/PPA.S49113
Mravčík, Viktor, et al. "Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review." Patient preference and adherence vol. 7 (2013): 1067-75. doi: https://doi.org/10.2147/PPA.S49113
Mravčík V, Strada L, Stolfa J, Bencko V, Groshkova T, Reimer J, Schulte B. Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review. Patient Prefer Adherence. 2013 Oct 17;7:1067-75. doi: 10.2147/PPA.S49113. PMID: 24204126; PMCID: PMC3804540.
Copy Download .nbib Format: NLM
Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed.

Patient preference and adherence

Crivera C, Nelson WW, Schein JR, Witt EA.
PMID: 27274206
Patient Prefer Adherence. 2016 May 17;10:795-805. doi: 10.2147/PPA.S106215. eCollection 2016.

BACKGROUND: Atrial fibrillation (AF) is associated with an increased risk of stroke. Anticoagulant (AC) therapies are effective at treating AF, but carry with them an increased risk of bleed. Research suggests that a large proportion of AF patients who...

Cite
Crivera C, Nelson WW, Schein JR, et al. Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed. Patient Prefer Adherence. 2016;10:795-805doi: 10.2147/PPA.S106215.
Crivera, C., Nelson, W. W., Schein, J. R., & Witt, E. A. (2016). Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed. Patient preference and adherence, 10795-805. https://doi.org/10.2147/PPA.S106215
Crivera, Concetta, et al. "Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed." Patient preference and adherence vol. 10 (2016): 795-805. doi: https://doi.org/10.2147/PPA.S106215
Crivera C, Nelson WW, Schein JR, Witt EA. Attitudes toward anticoagulant treatment among nonvalvular atrial fibrillation patients at high risk of stroke and low risk of bleed. Patient Prefer Adherence. 2016 May 17;10:795-805. doi: 10.2147/PPA.S106215. eCollection 2016. PMID: 27274206; PMCID: PMC4876102.
Copy Download .nbib Format: NLM
Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study.

Patient preference and adherence

Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N.
PMID: 27274207
Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016.

OBJECTIVE: The objective of this study is to evaluate the impact of sequential telephonic interviews on treatment persistence and daily adherence to insulin injections among insulin-naïve type 2 diabetes patients initiated on different insulin regimens in a 3-month period.METHODS:...

Cite
Yavuz DG, Bilen H, Sancak S, et al. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016;10:851-61doi: 10.2147/PPA.S100626.
Yavuz, D. G., Bilen, H., Sancak, S., Garip, T., Hekimsoy, Z., Sahin, I., Yilmaz, M., Aydin, H., Atmaca, A., Sert, M., Karakaya, P., Arpaci, D., Oguz, A., & Guvener, N. (2016). Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient preference and adherence, 10851-61. https://doi.org/10.2147/PPA.S100626
Yavuz, Dilek Gogas, et al. "Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study." Patient preference and adherence vol. 10 (2016): 851-61. doi: https://doi.org/10.2147/PPA.S100626
Yavuz DG, Bilen H, Sancak S, Garip T, Hekimsoy Z, Sahin I, Yilmaz M, Aydin H, Atmaca A, Sert M, Karakaya P, Arpaci D, Oguz A, Guvener N. Impact of telephonic interviews on persistence and daily adherence to insulin treatment in insulin-naïve type 2 diabetes patients: dropout study. Patient Prefer Adherence. 2016 May 17;10:851-61. doi: 10.2147/PPA.S100626. eCollection 2016. PMID: 27274207; PMCID: PMC4876103.
Copy Download .nbib Format: NLM
A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis.

Patient preference and adherence

Sajatovic M, Davis MS, Cassidy KA, Nestor J, Sams J, Fuentes-Casiano E.
PMID: 26089652
Patient Prefer Adherence. 2015 Jun 08;9:753-8. doi: 10.2147/PPA.S81724. eCollection 2015.

OBJECTIVE: As poor medication adherence is common in bipolar disorder (BD), technology-assisted approaches may help to monitor and enhance adherence. This study evaluated preliminary feasibility, patient satisfaction and effects on adherence, BD knowledge, and BD symptoms associated with the...

Cite
Sajatovic M, Davis MS, Cassidy KA, et al. A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis. Patient Prefer Adherence. 2015;9:753-8doi: 10.2147/PPA.S81724.
Sajatovic, M., Davis, M. S., Cassidy, K. A., Nestor, J., Sams, J., & Fuentes-Casiano, E. (2015). A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis. Patient preference and adherence, 9753-8. https://doi.org/10.2147/PPA.S81724
Sajatovic, Martha, et al. "A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis." Patient preference and adherence vol. 9 (2015): 753-8. doi: https://doi.org/10.2147/PPA.S81724
Sajatovic M, Davis MS, Cassidy KA, Nestor J, Sams J, Fuentes-Casiano E. A technology-enabled adherence enhancement system for people with bipolar disorder: results from a feasibility and patient acceptance analysis. Patient Prefer Adherence. 2015 Jun 08;9:753-8. doi: 10.2147/PPA.S81724. eCollection 2015. PMID: 26089652; PMCID: PMC4467735.
Copy Download .nbib Format: NLM
Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study.

Patient preference and adherence

Mattioli F, Siri G, Castelli F, Puntoni M, Zuccoli ML, Stimamiglio A, Martelli A.
PMID: 28860725
Patient Prefer Adherence. 2017 Aug 18;11:1423-1433. doi: 10.2147/PPA.S126486. eCollection 2017.

PURPOSE: Generic drugs use in the Liguria region is higher than the Italian average, but lower than in other European countries. No data exist about real-life prescription and level of awareness of generic drugs. In this study, we analyzed...

Cite
Mattioli F, Siri G, Castelli F, et al. Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient Prefer Adherence. 2017;11:1423-1433doi: 10.2147/PPA.S126486.
Mattioli, F., Siri, G., Castelli, F., Puntoni, M., Zuccoli, M. L., Stimamiglio, A., & Martelli, A. (2017). Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient preference and adherence, 111423-1433. https://doi.org/10.2147/PPA.S126486
Mattioli, F, et al. "Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study." Patient preference and adherence vol. 11 (2017): 1423-1433. doi: https://doi.org/10.2147/PPA.S126486
Mattioli F, Siri G, Castelli F, Puntoni M, Zuccoli ML, Stimamiglio A, Martelli A. Approval rating and opinion of outpatients and general practitioners toward generic drugs: a questionnaire-based real-world study. Patient Prefer Adherence. 2017 Aug 18;11:1423-1433. doi: 10.2147/PPA.S126486. eCollection 2017. PMID: 28860725; PMCID: PMC5572951.
Copy Download .nbib Format: NLM
Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall.

Patient preference and adherence

Athar MW, Mativo C, Landis R, Wright SM.
PMID: 27536072
Patient Prefer Adherence. 2016 Jul 29;10:1409-13. doi: 10.2147/PPA.S111190. eCollection 2016.

OBJECTIVE: To assess patients' preferences with respect to different methods of receiving test results while they were hospitalized and to determine whether the different modes of communication of the test results were associated with better recall.METHODS: Five discrete test...

Cite
Athar MW, Mativo C, Landis R, et al. Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall. Patient Prefer Adherence. 2016;10:1409-13doi: 10.2147/PPA.S111190.
Athar, M. W., Mativo, C., Landis, R., & Wright, S. M. (2016). Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall. Patient preference and adherence, 101409-13. https://doi.org/10.2147/PPA.S111190
Athar, Muhammad W, et al. "Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall." Patient preference and adherence vol. 10 (2016): 1409-13. doi: https://doi.org/10.2147/PPA.S111190
Athar MW, Mativo C, Landis R, Wright SM. Communication of laboratory data and diagnostic test results to hospitalized patients: a study of preferences and recall. Patient Prefer Adherence. 2016 Jul 29;10:1409-13. doi: 10.2147/PPA.S111190. eCollection 2016. PMID: 27536072; PMCID: PMC4973713.
Copy Download .nbib Format: NLM
Professionals' perception on the management of patients with dual disorders.

Patient preference and adherence

Roncero C, Szerman N, Terán A, Pino C, Vázquez JM, Velasco E, García-Dorado M, Casas M.
PMID: 27698553
Patient Prefer Adherence. 2016 Sep 19;10:1855-1868. doi: 10.2147/PPA.S108678. eCollection 2016.

BACKGROUND: There is a need to evaluate the professionals' perception about the consequences of the lack of therapeutic adherence in the evolution of patients with co-occurring disorders.METHODS: An online survey, released on the Socidrogalcohol [Spanish Scientific Society for Research...

Cite
Roncero C, Szerman N, Terán A, et al. Professionals' perception on the management of patients with dual disorders. Patient Prefer Adherence. 2016;10:1855-1868doi: 10.2147/PPA.S108678.
Roncero, C., Szerman, N., Terán, A., Pino, C., Vázquez, J. M., Velasco, E., García-Dorado, M., & Casas, M. (2016). Professionals' perception on the management of patients with dual disorders. Patient preference and adherence, 101855-1868. https://doi.org/10.2147/PPA.S108678
Roncero, Carlos, et al. "Professionals' perception on the management of patients with dual disorders." Patient preference and adherence vol. 10 (2016): 1855-1868. doi: https://doi.org/10.2147/PPA.S108678
Roncero C, Szerman N, Terán A, Pino C, Vázquez JM, Velasco E, García-Dorado M, Casas M. Professionals' perception on the management of patients with dual disorders. Patient Prefer Adherence. 2016 Sep 19;10:1855-1868. doi: 10.2147/PPA.S108678. eCollection 2016. PMID: 27698553; PMCID: PMC5034926.
Copy Download .nbib Format: NLM
Priorities in the primary care of persons experiencing homelessness: convergence and divergence in the views of patients and provider/experts.

Patient preference and adherence

Steward J, Holt CL, Pollio DE, Austin EL, Johnson N, Gordon AJ, Kertesz SG.
PMID: 26929607
Patient Prefer Adherence. 2016 Feb 12;10:153-8. doi: 10.2147/PPA.S75477. eCollection 2016.

PURPOSE: Homeless individuals face unique challenges in health care. Several US initiatives seeking to advance patient-centered primary care for homeless persons are more likely to succeed if they incorporate the priorities of the patients they are to serve. However,...

Cite
Steward J, Holt CL, Pollio DE, et al. Priorities in the primary care of persons experiencing homelessness: convergence and divergence in the views of patients and provider/experts. Patient Prefer Adherence. 2016;10:153-8doi: 10.2147/PPA.S75477.
Steward, J., Holt, C. L., Pollio, D. E., Austin, E. L., Johnson, N., Gordon, A. J., & Kertesz, S. G. (2016). Priorities in the primary care of persons experiencing homelessness: convergence and divergence in the views of patients and provider/experts. Patient preference and adherence, 10153-8. https://doi.org/10.2147/PPA.S75477
Steward, Jocelyn, et al. "Priorities in the primary care of persons experiencing homelessness: convergence and divergence in the views of patients and provider/experts." Patient preference and adherence vol. 10 (2016): 153-8. doi: https://doi.org/10.2147/PPA.S75477
Steward J, Holt CL, Pollio DE, Austin EL, Johnson N, Gordon AJ, Kertesz SG. Priorities in the primary care of persons experiencing homelessness: convergence and divergence in the views of patients and provider/experts. Patient Prefer Adherence. 2016 Feb 12;10:153-8. doi: 10.2147/PPA.S75477. eCollection 2016. PMID: 26929607; PMCID: PMC4760209.
Copy Download .nbib Format: NLM
Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness.

Patient preference and adherence

Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP.
PMID: 28424542
Patient Prefer Adherence. 2017 Mar 03;11:449-468. doi: 10.2147/PPA.S124658. eCollection 2017.

BACKGROUND: Antipsychotic medication reduces the severity of serious mental illness (SMI) and improves patient outcomes only when medicines were taken as prescribed. Nonadherence to the treatment of SMI increases the risk of relapse and hospitalization and reduces the quality...

Cite
Velligan DI, Sajatovic M, Hatch A, et al. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017;11:449-468doi: 10.2147/PPA.S124658.
Velligan, D. I., Sajatovic, M., Hatch, A., Kramata, P., & Docherty, J. P. (2017). Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient preference and adherence, 11449-468. https://doi.org/10.2147/PPA.S124658
Velligan, Dawn I, et al. "Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness." Patient preference and adherence vol. 11 (2017): 449-468. doi: https://doi.org/10.2147/PPA.S124658
Velligan DI, Sajatovic M, Hatch A, Kramata P, Docherty JP. Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness. Patient Prefer Adherence. 2017 Mar 03;11:449-468. doi: 10.2147/PPA.S124658. eCollection 2017. PMID: 28424542; PMCID: PMC5344423.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 2293 entries